Belvedere Trading LLC Oramed Pharmaceuticals Inc. Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.21 - $12.03 $32,248 - $62,471	-5,193 Reduced 28.29%	13,164 $158,000
Q3 2022 Oct 26, 2022	SELL	$4.6 - $9.91 $102,731 - $221,320	-22,333 Reduced 54.89%	18,357 $124,000
Q2 2022 Jul 21, 2022	BUY	$3.72 - $9.0 $151,366 - $366,210	40,690 New	40,690 $343,000
Q4 2021 Jan 25, 2022	SELL	$12.98 - $29.75 $155,396 - $356,167	-11,972 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$12.13 - $23.82 $145,220 - $285,173	11,972 New	11,972 $269,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.1M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.